Filing Details
- Accession Number:
- 0001209191-22-003402
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-14 20:42:49
- Reporting Period:
- 2022-01-13
- Accepted Time:
- 2022-01-14 20:42:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1601830 | Recursion Pharmaceuticals Inc. | RXRX | Biological Products, (No Disgnostic Substances) (2836) | 464099738 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1856369 | Christopher Gibson | C/O Recursion Pharmaceuticals 41 S. Rio Grande Street Salt Lake City UT 84101 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2022-01-13 | 87,000 | $0.00 | 110,470 | No | 4 | C | Direct | |
| Class A Common Stock | Disposition | 2022-01-13 | 78,206 | $14.26 | 32,264 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2022-01-13 | 8,794 | $14.96 | 23,470 | No | 4 | S | Direct | |
| Class A Common Stock | Acquisiton | 2022-01-14 | 254,000 | $0.00 | 277,470 | No | 4 | C | Direct | |
| Class A Common Stock | Disposition | 2022-01-14 | 254,000 | $13.57 | 23,470 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | C | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Class B Common Stock | Disposition | 2021-12-28 | 75,000 | $0.00 | 75,000 | $0.00 |
| Class A Common Stock | Class B Common Stock | Disposition | 2022-01-13 | 87,000 | $0.00 | 87,000 | $0.00 |
| Class A Common Stock | Class B Common Stock | Disposition | 2022-01-14 | 254,000 | $0.00 | 254,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 8,119,342 | No | 5 | G | Direct | ||
| 8,032,342 | No | 4 | C | Direct | ||
| 7,778,342 | No | 4 | C | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Stock Option (Right to Buy) | $2.47 | 2030-12-30 | 1,471,354 | 1,471,354 | Direct | |
| Class A Common Stock | Class B Common Stock | $0.00 | 550,000 | 550,000 | Indirect | ||
| Class A Common Stock | Class B Common Stock | $0.00 | 550,000 | 550,000 | Indirect | ||
| Class A Common Stock | Class B Common Stock | $0.00 | 146,875 | 146,875 | Indirect |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2030-12-30 | 1,471,354 | 1,471,354 | Direct |
| 550,000 | 550,000 | Indirect | |
| 550,000 | 550,000 | Indirect | |
| 146,875 | 146,875 | Indirect |
Footnotes
- Represents the conversion of Class B Common Stock into Class A Common Stock.
- Shares were sold by a lender to the Reporting Person to satisfy a margin call related to a loan in which the shares served as collateral.
- This transaction was executed in multiple trades at prices ranging from $13.80 to $14.78. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $14.80 to $15.12. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $13.09 to $14.03. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
- The option, originally for 1,500,000 shares, of which 28,646 shares have been exercised, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
- The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
- The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
- The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.
Billionaire Hedge Funds
